178 related articles for article (PubMed ID: 25154973)
1. Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer.
Ema A; Waraya M; Yamashita K; Kokubo K; Kobayashi H; Hoshi K; Shinkai Y; Kawamata H; Nakamura K; Nishimiya H; Katada N; Watanabe M
Cancer Med; 2015 Jan; 4(1):90-100. PubMed ID: 25154973
[TBL] [Abstract][Full Text] [Related]
2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
3. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
[TBL] [Abstract][Full Text] [Related]
4. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
[TBL] [Abstract][Full Text] [Related]
6. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS; Kim MA; Kim TM; Lee SH; Kim DW; Im SA; Kim TY; Kim WH; Yang HK; Heo DS; Bang YJ; Lee KU; Choe KJ; Kim NK
Br J Cancer; 2009 Mar; 100(5):732-8. PubMed ID: 19259093
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer.
Yamashita K; Ooki A; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Anticancer Res; 2008; 28(1B):435-41. PubMed ID: 18383882
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer.
Atmaca A; Werner D; Pauligk C; Steinmetz K; Wirtz R; Altmannsberger HM; Jäger E; Al-Batran SE
BMC Cancer; 2012 Nov; 12():524. PubMed ID: 23153332
[TBL] [Abstract][Full Text] [Related]
10. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
11. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer.
Yamashita K; Hosoda K; Ema A; Watanabe M
Eur J Surg Oncol; 2016 Sep; 42(9):1253-60. PubMed ID: 27017273
[TBL] [Abstract][Full Text] [Related]
12. Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes?
Lee SY; Hwang I; Park YS; Gardner J; Ro JY
Int J Oncol; 2010 Jun; 36(6):1461-7. PubMed ID: 20428770
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.
Wang L; Zhu JS; Song MQ; Chen GQ; Chen JL
World J Gastroenterol; 2006 Nov; 12(43):6949-54. PubMed ID: 17109515
[TBL] [Abstract][Full Text] [Related]
14. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients.
Fukuda N; Sugiyama Y; Midorikawa A; Mushiake H
World J Surg; 2009 Nov; 33(11):2378-82. PubMed ID: 19760318
[TBL] [Abstract][Full Text] [Related]
16. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients.
Yamashita H; Deng J; Liang H; Seto Y
Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043
[TBL] [Abstract][Full Text] [Related]
19. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of No.12 lymph node dissection for advanced gastric cancer].
You X; Wang Y; Li W; Zhao X; Cheng Z; Xu N; Huang C; Liu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):283-288. PubMed ID: 28338161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]